Use of ketoconazole in the treatment of Cushing's syndrome - PubMed

Use of ketoconazole in the treatment of Cushing's syndrome

P Loli et al. J Clin Endocrinol Metab. 1986 Dec.

Abstract

The therapeutic value of ketoconazole for long term treatment of patients with Cushing's syndrome was studied. Seven patients with Cushing's disease and one with an adrenal adenoma received 600-800 mg/day ketoconazole for 3-13 months. Plasma ACTH, cortisol, and dehydroepiandrosterone sulfate levels and urinary cortisol, 17-ketosteroid, and tetrahydro-11-deoxycortisol excretion were determined periodically during the treatment period. Plasma ACTH and cortisol responses to CRH stimulation were determined before and during treatment. Rapid and subsequently persistent clinical improvement occurred in each patient; plasma dehydroepiandrosterone sulfate and urinary 17-ketosteroid and cortisol excretion decreased soon after the initiation of treatment, subsequently remaining normal or nearly so throughout the treatment period. Urinary tetrahydro-11-deoxycortisol excretion increased significantly. Plasma cortisol levels decreased. Plasma ACTH levels did not change, and individual plasma ACTH and cortisol increments in response to CRH were comparable before and during treatment. The cortisol response to insulin-induced hypoglycemia improved in one patient and was restored to normal in another. The seven patients tested recovered normal adrenal suppressibility in response to a low dose of dexamethasone during ketoconazole treatment. Ketoconazole is effective for long term control of hypercortisolism of either pituitary or adrenal origin. Its effect appears to be mediated by inhibition of adrenal 11 beta-hydroxylase and 17,20-lyase, and it, in some unknown way, prevents the expected rise in ACTH secretion in patients with Cushing's disease.

Similar articles

• Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.

  Komanicky P, Spark RF, Melby JC. Komanicky P, et al. J Clin Endocrinol Metab. 1978 Nov;47(5):1042-51. doi: 10.1210/jcem-47-5-1042. J Clin Endocrinol Metab. 1978. PMID: 233687

• Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.

  Engelhardt D, Jacob K, Doerr HG. Engelhardt D, et al. Klin Wochenschr. 1989 Feb 15;67(4):241-7. doi: 10.1007/BF01717326. Klin Wochenschr. 1989. PMID: 2538676 Clinical Trial.

• Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.

  Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H. Horiba N, et al. J Clin Endocrinol Metab. 1995 Aug;80(8):2336-41. doi: 10.1210/jcem.80.8.7629226. J Clin Endocrinol Metab. 1995. PMID: 7629226

• Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.

  Berwaerts JJ, Verhelst JA, Verhaert GC, Verhaegen AA, Abs RE. Berwaerts JJ, et al. J Am Geriatr Soc. 1998 Jul;46(7):880-4. doi: 10.1111/j.1532-5415.1998.tb02723.x. J Am Geriatr Soc. 1998. PMID: 9670876 Review.

• Evaluation and treatment of Cushing's syndrome.

  Nieman LK, Ilias I. Nieman LK, et al. Am J Med. 2005 Dec;118(12):1340-6. doi: 10.1016/j.amjmed.2005.01.059. Am J Med. 2005. PMID: 16378774 Review.

Cited by

• Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

  Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Biller BM, et al. J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62. doi: 10.1210/jc.2007-2734. Epub 2008 Apr 15. J Clin Endocrinol Metab. 2008. PMID: 18413427 Free PMC article. Review.

• Steroid biosynthesis inhibitors in Cushing's syndrome.

  Engelhardt D. Engelhardt D. Clin Investig. 1994 Jul;72(7):481-8. doi: 10.1007/BF00207474. Clin Investig. 1994. PMID: 7981573 Review. No abstract available.

• The Treatment of Cushing's Disease.

  Pivonello R, De Leo M, Cozzolino A, Colao A. Pivonello R, et al. Endocr Rev. 2015 Aug;36(4):385-486. doi: 10.1210/er.2013-1048. Epub 2015 Jun 11. Endocr Rev. 2015. PMID: 26067718 Free PMC article. Review.

• Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males.

  Waite NM, Edwards DJ, Arnott WS, Warbasse LH. Waite NM, et al. Antimicrob Agents Chemother. 1989 Nov;33(11):1875-7. doi: 10.1128/AAC.33.11.1875. Antimicrob Agents Chemother. 1989. PMID: 2610498 Free PMC article.

• Evaluation of clinical and hormonal effects in hirsute women treated with ketoconazole.

  Conget JI, Halperin I, Ferrer J, González-Clemente JM, Martinez-Osaba MJ, Vilardell E. Conget JI, et al. J Endocrinol Invest. 1990 Dec;13(11):867-70. doi: 10.1007/BF03349644. J Endocrinol Invest. 1990. PMID: 2151039

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information